Related Experiment Videos

In Reply to Saini and Jalali

Barbara J Fisher¹

¹Radiation Oncology, Western University, London, Ontario, Canada.

International Journal of Radiation Oncology, Biology, Physics

|October 18, 2020

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma.

JCO precision oncology·2021

Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer.

International journal of radiation oncology, biology, physics·2021

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424.

International journal of radiation oncology, biology, physics·2020

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.

American journal of clinical oncology·2020

High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.

International journal of radiation oncology, biology, physics·2019

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.

JAMA oncology·2018

See all related articles